GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Seems like PFE has hit the bottom at 24.81. Stock is staging a rebound.
Added some shares at 24.93 to DCA.
No comment yet